EDARBI
Takeda Pharmaceutical Company Limited
Application Filed: 2011-09-15
Trademark Application Details
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85423268 |
| Registration Number | 4170666 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Barclay Damon LLP |
| Attorney Name | Jason S. Nardiello |
| Attorney Docket Number | 3092451 |
| Law Office Assigned | L30 |
| Employee Name | THOMAS, JANICE |
Timeline
| 2011-09-15 | Application Filed |
| 2012-04-24 | Published for Opposition |
| 2012-07-10 | Trademark Registered |
| 2018-04-25 | Location: TMEG LAW OFFICE 103 |
| 2018-04-25 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Takeda Pharmaceutical Company Limited |
| Address | 1-1, Doshomachi 4-Chome, Chuo-ku Osaka JP |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260109 | Circles having animals as a border; Circles having geometric figures as a border; Circles having humans as a border; Circles having objects as a border; Circles having plants as a border; Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle. |
| 260515 | Four or more triangles; Triangles |
| 260521 | Triangles that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2011-09-19 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-09-20 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE MAILED | 2011-09-21 | 3 MDSC O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2012-01-02 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2012-01-03 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2012-01-03 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2012-01-03 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-02-14 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2012-03-02 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2012-03-08 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2012-03-08 | 11 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-03-12 | 12 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-03-16 | 13 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-04-04 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2012-04-24 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2012-04-24 | 16 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2012-07-10 | 17 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2017-07-10 | 18 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2018-04-13 | 19 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-04-25 | 20 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2018-04-25 | 21 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2018-04-25 | 22 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-07-10 | 23 REM2 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-12-21 | 24 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-12-21 | 25 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-12-21 | 26 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2021-12-21 | 27 EWAF I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-12-21 | 28 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-12-21 | 29 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-12-21 | 30 CHAN I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2022-05-27 | 31 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-12-11 | 32 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-12-11 | 33 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2022-12-11 | 34 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-12-11 | 35 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 EDARBI 85423268 4170666 Live/Registered |
Takeda Pharmaceutical Company Limited 2011-09-15 |
 EDARBI 85262013 not registered Dead/Abandoned |
Takeda Pharmaceutical Company Limited 2011-03-09 |
 EDARBI 79075482 3807333 Live/Registered |
Takeda Pharmaceutical Company Limited 2009-10-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 